The scariest thing about gray-market peptides is how little we know

The peptide wild west is hard to quantify. | Image: Cath Virginia / The Verge, Getty Images This is Optimizer, a weekly newsletter sent from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they're going to change your life. Opt in for Optimizer here. Finding concrete data about gray-market peptides is a Sisyphean task. Unlike bona fide clinical drug trials, there are no official numbers. There's little to no safety data. Some peptides ha